{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05667532",
            "orgStudyIdInfo": {
                "id": "2022-0651"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2022-10200",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Trials Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts",
            "officialTitle": "The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "the-c-merit-screening-cohort-contrast-enhanced-mammography-for-breast-cancer-screening-and-risk-assessment-in-women-with-dense-breasts"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-12-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-11-30",
            "studyFirstSubmitQcDate": "2022-12-19",
            "studyFirstPostDateStruct": {
                "date": "2022-12-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To learn whether a new imaging technology, Contrast-Enhanced Mammography (CEM), compared to standard mammography, can better detect breast cancers in women with dense breasts",
            "detailedDescription": "Primary Objectives:\n\n* To establish a cohort of 1,000 female MDACC patients with dense breasts who undergo screening contrast-enhanced mammography.\n* To establish a comprehensive integrated database of imaging, clinical data, health measurements, and questionnaire data including data from the companion protocol PA17-0584.\n\nSecondary Objectives:\n\n* To perform within-subject comparison of the cancer detection rate between CEM and FFDM.\n* To perform within-subject comparison of the sensitivity, specificity, and recall rates of CEM compared to low-energy (LE) images (FFDM equivalent) and compared to a combination of LE and DBT images among women with dense breasts.\n* To evaluate the effect of the availability of prior imaging for comparison on the recall rates of CEM, FFDM and DBT.\n* In patients who undergo screening breast ultrasound as a standard of care, to evaluate the performance of screening ultrasound for breast cancer detection and compare it with other imaging modalities of CEM, LE images, and DBT.\n\nExploratory Objectives:\n\n* To combine imaging, blood biomarkers, health measurements and questionnaire data for assessment of breast cancer risk.\n* To evaluate if the intensity of background parenchymal enhancement on CEM predicts breast cancer risk in women with dense breasts.\n* To evaluate if patients consider CEM as a potentially acceptable imaging modality for routine breast cancer screening."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 1000,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Contrast Enhanced Mammography",
                    "interventionNames": [
                        "Diagnostic Test: Contrast Enhanced Mammography"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Contrast Enhanced Mammography",
                    "description": "Screening Modality",
                    "armGroupLabels": [
                        "Contrast Enhanced Mammography"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To identify female MDACC patients with dense breasts who undergo contrast-enhanced mammography",
                    "timeFrame": "through study completion; an average of 1 year."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patients 30-75 years of age with dense breasts (ACR BI-RADS categories C and D) who undergo routine yearly mammography at participating MDACC sites\n2. Willingness to co-enroll or currently enrolled in PA17-0584\n3. Willingness to participate in the study and ability to provide informed consent\n\nExclusion Criteria:\n\n1. Self-reported new breast symptoms since last mammogram including nipple discharge, palpable mass, skin dimpling, or focal pain.\n2. Current or recent (within the prior 6 months) history of pregnancy or breast feeding\n3. Personal history of breast cancer (DCIS or invasive breast cancer)\n4. Treatment of any other type of cancer within the past 5 years excluding in-situ cervical and non-melanoma skin cancer\n5. Breast biopsy within 6 months\n6. Breast surgery within 12 months\n7. Breast MRI, MBI, or CEM performed within 24 months\n8. Known allergy to iodine-containing contrast agents\n9. History of anaphylactic reaction to any substance that required hospitalization or IV placement in a patient with no known prior uneventful exposure to iodine-based IV contrast\n10. Renal insufficiency (as defined by UTMDACC policy 3.30- attachment 1 (appendix D)",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "30 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "MD Anderson Cancer Center",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Olena Weaver, MD",
                    "role": "CONTACT",
                    "phone": "(713) 745-4555",
                    "email": "ooweaver@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Olena Weaver, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Olena Weaver, MD",
                            "role": "CONTACT",
                            "phone": "713-745-4555",
                            "email": "ooweaver@mdanderson.org"
                        },
                        {
                            "name": "Olena Weaver, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "M D Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}